Similar companies
| Company | Revenue | |
|---|---|---|
| No data for previous quarter available yet. | ||
Income Statement (USD)
| Q4 '25 | QoQ | |
|---|---|---|
| Revenue | 11.5B | 0.8% |
| Gross Profit | 6.54B | 3.1% |
| Cost of Revenue | 4.92B | 2.2% |
| Operating expense | 4.29B | 0.5% |
| Net Income | 1.78B | 8% |
| EBITDA | 2.52B | 18.4% |
Balance Sheet (USD)
| Q4 '25 | QoQ | |
|---|---|---|
| Shares Outstanding | 1.75B | 0.1% |
Cash Flow (USD)
| Q4 '25 | QoQ |
|---|
EPS
Financial Highlights for Abbott Laboratories in Q4 '25
Abbott Laboratories reported a revenue of 11.5B, which is a 0.8% change from the previous quarter. An increase in revenue typically indicates growing demand for the company's products or services. This positive change in revenue is a good sign, suggesting that the company's sales are moving in the right direction.
Gross Profit stood at 6.54B, marking a 3.1% change since the last quarter. Gross profit showcases the efficiency in production and sales processes.
Cost of Revenue was 4.92B, a -2.2% difference from the previous quarter. A rising cost of revenue may suggest increased production or sales costs, which can impact margins. However, if accompanied by a proportionate rise in revenue, it could indicate scaling operations.
Operating Expenses for this period were 4.29B, showing a -0.5% change from the last quarter. Operating expenses cover the costs of running daily business operations. A significant increase might indicate inefficiencies or investments in growth, while a decrease could suggest cost-saving measures or potential underinvestment in key areas.
Net Income for the quarter was 1.78B, showing a 8% change from the prior quarter. Net income provides a clear picture of the company's profitability after all expenses. An increase suggests the company is becoming more profitable, while a decrease may raise concerns about the company's financial health, unless there are specific one-time costs or investments.
The company's EBITDA for the quarter was 2.52B, showing a -18.4% change from the previous period. EBITDA gives insight into the company's operational profitability, excluding non-operating expenses like interest and taxes. A rising EBITDA indicates strong operational performance, while a declining EBITDA may signal operational challenges or increased costs.
It was a positive quarter for Abbott Laboratories with growth in revenue, gross profit, and net income. A decline in EBITDA signals potential operational challenges or increased costs.
